Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C

Fontana RJ, Sanyal AJ, Ghany MG, Lee WM, Reid AE, Naishadham D, et al. Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C. Gastroenterology. 2010;138(7):2321-2331.

Publication Type:

Journal Article

Authors:

Robert J Fontana; Sanyal, A.J.; Ghany, M.G.; Lee, W.M.; Reid, A.E.; Naishadham, D.; G.T. Everson; Kahn, J.A.; A M Di Bisceglie; Szabo, G.; Morgan, T.R.; Everhart, J.E.; HALT-C trial group

Source:

Gastroenterology, Volume 138, Issue 7, p.2321-2331 (2010)

Keywords:

Adult, complications, Disease, Disease Progression, drug therapy, Endoscopy, Esophageal and Gastric Varices, etiology, Female, Fibrosis, Hemorrhage, hepatitis, Hepatitis C, Hepatitis C,Chronic, Humans, Hyaluronic Acid, Incidence, interferon, Interferon Alfa-2b, Interferon-alpha, Internal Medicine, Laboratories, Male, Medication Adherence, Medicine, methods, Michigan, Middle Aged, Patients, peginterferon, peginterferon alfa-2b, Platelet Count, Polyethylene Glycols, Proteins, Recombinant Proteins, Research, Research Support, Risk, Serum, therapeutic use, therapy, treatment

Notes:

PMC2883673

Cited On:

HCV Testing and Linkage to Care

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/20211180

Export Citation:

RIS Format

Top